Evidence map›Paper›PMID 34049617›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2021

The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB.

L Mantshonyane, B Kgwaadira, R Gross

Abstract readLetter
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

L MantshonyaneThe Botswana-University of Pennsylvania Partnership, Department of Biostatistics Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine, Gaborone, Botswana.
B KgwaadiraBotswana Ministry of Health & Wellness, Botswana National TB Program, Gaborone, Botswana.
R GrossThe University of Pennsylvania, Philadelphia, PA, USA.

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
HIV Research Training Program for BotswanaD43TW009781 · FIC · UNIVERSITY OF PENNSYLVANIA · PI GROSS, ROBERT · 2014 to 2018
$1.7M
FIC NIH HHS D43 TW009781NIAID NIH HHS P30 AI045008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsTuberculosis, PulmonaryHumansRecurrenceAntitubercular Agents

Identifiers

PMID34049617
PMCPMC8500578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.